Ponesimod recommended for relapsing-remitting multiple sclerosis
Clinical trial evidence shows that people who have ponesimod have fewer relapses than people who have teriflunomide., according to NICE final draft guidance.
Multiple Sclerosis: Raising the bar
This infographic reveals the scale of the impact of MS in the UK and provides a specific focus on the prevention of emergency MS admissions
Published
OnMedica provides high-quality, easy to digest content and CPD for UK-based GPs and clinicians.
Our team of expert editors and clinicians develops content across a wide range of topics in a variety of formats—expert articles, bitesize news and quizzes, courses, videos, and more. You can explore OnMedica via the homepage, drop down menu or by typing your topic of choice in the search bar. Why not find out how OnMedica can help you to keep up to date quickly and easily?
You may also be interested in...
